Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects
Clinical trial NCT02651727 · TERMINATED
Trial details
- NCT number
- NCT02651727
- Sponsor
- Verastem, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-01-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.